QID 355633

Date Published: 2023-07-24

QID 355633: Amazon Linux Security Advisory for dotnet6.0 : ALAS2023-2023-242

.net denial of service vulnerability. (
( CVE-2023-21538) .net, .net framework, and visual studio remote code execution vulnerability (cve-2023-24895) .net, .net framework, and visual studio elevation of privilege vulnerability (cve-2023-24936) .net, .net framework, and visual studio denial of service vulnerability (cve-2023-29331) nuget client remote code execution vulnerability (cve-2023-29337) .net and visual studio elevation of privilege vulnerability (cve-2023-32032) .net and visual studio elevation of privilege vulnerability (cve-2023-33135)



Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a securitybreach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as High - 7.8 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Please refer to Amazon advisory: ALAS2023-2023-242 for affected packages and patching details, or update with your package manager.
    Vendor References

    CVEs related to QID 355633

    CVE-2023-24895 | CVE-2023-29337 | CVE-2023-32032 | CVE-2023-24936 | CVE-2023-21538 | CVE-2023-29331 | CVE-2023-33135 |
    Software Advisories
    Advisory ID Software Component Link
    ALAS2023-2023-242 amazon linux 2023 URL Logo alas.aws.amazon.com/AL2023/ALAS-2023-242.html
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].